Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Acute myeloid leukemia

Need for routine examination of left ventricular ejection fraction in patients with AML

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35:893–911.

    Article  Google Scholar 

  2. O’Donnell M, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, et al. Acute myeloid leukemia guidelines 2017. J Natl Compr Canc Netw. 2017;15:926–57.

    Article  Google Scholar 

  3. Curigliano G, Cardinale D, Suter T, Plataniotis G, Azambuja ED, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 suppl 7:vii155–66.

    Article  Google Scholar 

  4. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911–39.

    Article  Google Scholar 

  5. Zamorano JL, Lancellotti P, Muñoz DR, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016;37:2768–80.

    Article  Google Scholar 

  6. Volkova M, Russell R. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2012;7:214–20.

    Article  Google Scholar 

  7. Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, Dascenzo F, Malavasi V, et al. Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol. 2013;112:1980–4.

    Article  CAS  Google Scholar 

  8. Anderlini P, Benjamin RS, Wong FC, Kantarjian HM, Andreeff M, Kornblau SM, et al. Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia. J Clin Oncol. 1995;13:2827–34.

    Article  CAS  Google Scholar 

  9. Khan H, Gardner K, Shaw C, Halpern A, Huebner E, Percival ME, et al. Table 1 is original data that cannot be found in other documents. It was analyzed for the purpose of this submitted letter to the editor titled “Need for routine examination of left ventricular ejection fraction in patients with AML”. Leukemia in press.

  10. Thavendiranathan P, Abdel-Qadir H, Fischer HD, Liu Y, Camacho X, Amir E, et al. Risk-imaging mismatch in cardiac imaging practices for women receiving systemic therapy for early-stage breast cancer: a population-based cohort study. J Clin Oncol. 2018;36:2980–7.

    Article  CAS  Google Scholar 

  11. Dang CT, Yu AF, Liu J, Steingart R. Risk-imaging mismatch: why is there a disconnect? J Clin Oncol. 2018;36:2975–7.

    Article  Google Scholar 

  12. Peddi P, Master SR, Dwary AD, Ravipati HP, Patel AH, Pasam A, et al. Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines. Breast J. 2018;25:62–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

EE and HK conceived the project, analyzed data, and wrote the paper. KG and CS provided data. AH, EH, MP, SM, MS, RW, and PB provided suggestions.

Corresponding author

Correspondence to Elihu H. Estey.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, H.M., Gardner, K.M., Shaw, C. et al. Need for routine examination of left ventricular ejection fraction in patients with AML. Leukemia 34, 1169–1171 (2020). https://doi.org/10.1038/s41375-019-0637-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41375-019-0637-z

Search

Quick links